46 results on '"Chukwueke, Ugonma N"'
Search Results
2. A population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act.
3. Barriers to accrual and enrollment in brain tumor trials
4. Enhancing neuro-oncology care through equity-driven applications of artificial intelligence.
5. Leptomeningeal metastases from solid tumors: A Society for Neuro-Oncology and American Society of Clinical Oncology consensus review on clinical management and future directions.
6. Disparities and Inequities Among Patients with Central Nervous System Tumor
7. Neurological Complications of Immune-Based Therapies
8. Neurological Complications of Targeted Therapies
9. Palbociclib demonstrates intracranial activity in progressive brain metastases harboring cyclin-dependent kinase pathway alterations
10. Integration of rare cell capture technology into cytologic evaluation of cerebrospinal fluid specimens from patients with solid tumors and suspected leptomeningeal metastasis
11. Central Nervous System Lymphoma
12. Contributors List
13. Cancer-associated plexopathy
14. Defining interventions and metrics to improve diversity in CNS clinical trial participation: A SNO and RANO effort.
15. Validation of targeted next‐generation sequencing of cell‐free DNA from archival cerebrospinal fluid specimens for the detection of somatic variants in cancer involving the leptomeninges: Cytopathologic and radiographic correlation.
16. Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization
17. Defining interventions and metrics to improve diversity in CNS clinical trial participation: a SNO and RANO effort
18. Validation of targeted next‐generation sequencing of cell‐free DNA from archival cerebrospinal fluid specimens for the detection of somatic variants in cancer involving the leptomeninges: Cytopathologic and radiographic correlation
19. Medical management of meningiomas
20. Clinical efficacy and safety of chimeric antigen receptor T‐cell therapy for mantle cell lymphoma with secondary central nervous system involvement
21. Advances in Management of Brain and Leptomeningeal Metastases
22. Neurological Complications of Targeted Therapies
23. Neurological Complications of Immune-Based Therapies
24. Contributors
25. Clinical presentation in adults—Brain
26. Precision Medical Approaches to the Diagnoses and Management of Brain Metastases
27. Evaluating hematologic parameters in newly diagnosed and recurrent glioblastoma: Prognostic utility and clinical trial implications of myelosuppression
28. World Health Organization 2021 Classification of Central Nervous System Tumors and Implications for Therapy for Adult-Type Gliomas
29. Resolving the phylogenetic origin of glioblastoma via multifocal genomic analysis of pre-treatment and treatment-resistant autopsy specimens
30. Chapter 22 - Cancer-associated plexopathy
31. SNO 2020 diversity survey: defining demographics, racial biases, career success metrics and a path forward for the field of neuro-oncology
32. Chapter 28 - Medical management of meningiomas
33. A Population Study of Clinical Trial Accrual for Women and Minorities in Neuro-Oncology Following the NIH Revitalization Act
34. Delivering Equitable Care to Underserved Neuro-oncology Populations
35. population study of clinical trial accrual for women and minorities in neuro-oncology following the NIH Revitalization Act.
36. Colaboradores
37. Chapter 1 - Clinical presentation in adults—Brain
38. Socioeconomic Disparities Associated With MGMT Promoter Methylation Testing for Patients With Glioblastoma
39. 46. PAN-CANCER ANALYSIS OF ORTHOTOPIC PATIENT DERIVED XENOGRAFTS FROM BRAIN METASTASES
40. List of Contributors
41. Predictors and early survival outcomes of maximal resection in WHO grade II 1p/19q-codeleted oligodendrogliomas
42. Phase II trial of ponatinib in patients with bevacizumab‐refractory glioblastoma
43. Use of the Response Assessment in Neuro-Oncology (RANO) criteria in clinical trials and clinical practice
44. Predictors and early survival outcomes of maximal resection in WHO grade II 1p/19q-codeleted oligodendrogliomas.
45. Sequencing brain metastases and opportunities for targeted therapies
46. Medical management of meningiomas.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.